What’s the difference between Summarize Custom Fields and Summarize Custom Fields Incrementally in Empower Software?
This week, we will create an Intersample Custom Field with a summary function, such as average or %RSD, and learn how Empower Software calculates the average area or the %RSD of the area (i.e., for a peak of interest over multiple samples).
Scientists from Waters and Pfizer collaborated to take on the challenge of engineering a novel reversed-phase LC column for high-throughput separations with enhanced resolution, selectivity, and recovery of target mAbs and ADCs.
What procedures can an analyst use to ensure that a chromatography system is ready to begin analyzing samples, without the fear that the system suitability tests would immediately fail?
What if we wanted to make a calculation in Empower Software involving a peak in one chromatogram and a peak in another chromatogram? In this case, you’d use an Intersample Custom Field. See how to apply it.
Reflecting on a common concern in newborn screening: Reliability.
For biopharmaceutical organizations working with contract labs, it’s important to consider how data and methods will be transferred and how generated data will be managed so that it meets data integrity and compliance requirements.
What if we have more than one criterion to determine if the sample passes or fails? What if we have multiple criteria for a system suitability test? Rather than having to look at multiple fields to determine if our sample passes or fails, let’s create one custom field in Empower Software to evaluate all of the important fields and return a pass/fail.
In Japan, Professor Masanori Kataoka finds that the ACQUITY QDa Mass Detector is suitable for the synthesis and analysis of oligonucleotides – and sees ways to expand its use.
Waters recently partnered with United States Pharmacopeia (USP) experts to host a webinar discussing the upcoming changes in the pending USP General Chapter on chromatography that will provide increased flexibility for gradient methods. Here’s an extended Q&A from the webinar.